The Effect of Remote Reiki Treatment on Hopelessness, Fatigue and Pain in Patients Awaiting Organ Transplantation

NCT07394660 | Completed

• 2 other identifiers: BozokUnıversitythe author himself
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The treatment and care of chronic kidney failure is a long-term process, and patients are significantly affected by this condition. The fact that patients spend much of their daily lives attending hemodialysis sessions two or three times a week considerably limits their life activities. dition to medical treatment, a non-pharmacological Therefore, individuals may become partially or completely dependent. Coping with various symptoms brought on by this chronic disease, adapting to the restrictions required by treatment, preventing complications, and improving quality of life also bring about physical, cognitive, and psychological challenges. Patients are aware that they can only regain their previous health through organ transplantation; however, since it is uncertain when a suitable donor will be found, they may experience intense feelings of hopelessness. The chronic illness itself and the hemodialysis sessions frequently lead to symptoms such as pain and fatigue. In admethod such as distant Reiki may be supportive in coping with symptoms like hopelessness, fatigue, and pain. Numerous evidence-based studies in the literature have demonstrated that distant Reiki practices support symptom management in many chronic diseases through their effects on the parasympathetic nervous system. However, the effects of distant Reiki on hopelessness, fatigue, and pain in individuals awaiting organ donation have not yet been investigated.

Conditions

Reiki; Organ or Tissue Transplant; Complications

Keywords

reiki; organ transplant; nursing; pain; Hopelessness

Outcome Measures

Primary Outcomes (3)

• Hopelessness Level

  Hopelessness level will be assessed using the Beck Hopelessness Scale (BHS). The scale consists of 20 items and measures negative expectations about the future. Higher total scores indicate greater levels of hopelessness. Total scale score (0-20) Unit of Measure: Scale total score (0-20)

  From enrollment to the end of treatment at 8 weeks

• Pain Intensity and Pain Interference

  Pain intensity and pain-related interference with daily activities will be assessed using the numeric raito scale (NRS). The instrument evaluates pain severity and its impact on functioning. Pain severity score and pain interference score Unit of Measure: Scale total score (0-10)

  From enrollment to the end of treatment at 8 weeks

• Fatigue Severity

  Fatigue severity will be measured using the Fatigue Severity Scale (FSS), a 9-item self-report questionnaire evaluating the impact of fatigue on daily functioning. Higher scores indicate greater fatigue severity. Unit of Measure: Total scale score (1-7)

  Baseline (first dialysis day), at 4 weeks (end of intervention), and 1 month after the final intervention session

Secondary Outcomes (4)

• Systolic Blood Pressure

  Baseline to 8 weeks

• Diastolic Blood Pressure

  Baseline to 8 weeks

• Heart Rate

  Baseline to 8 weeks

• Body Temperature

  Baseline to 8 weeks

Study Arms (2)

1

EXPERIMENTAL

remote reiki

Behavioral: remote reiki

2

NO INTERVENTION

control

Interventions

remote reiki BEHAVIORAL

Patients in the intervention group will be contacted by telephone. They will be provided with a suitable environment. A certified assistant researcher will initiate the remote Reiki application. Each application is expected to last an average of 35-40 minutes. The first remote Reiki session will be conducted on the evening of the patient's haemodialysis day. The sessions will take place three times a week for a total of four weeks. After the application is completed, vital signs will be taken again from the intervention group patients, and the Beck Hopelessness Scale, Fatigue Severity Scale, and Brief Pain Inventory will be completed. The data collection tool will be completed a second time the day after the last application and a third time one month later. The effects of Reiki therapy on hopelessness, fatigue, and pain will be evaluated using the Personal Information Form, Beck Hopelessness Scale, Fatigue Severity Scale, and Brief Pain Inventory.

1

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients who have been undergoing haemodialysis for ≥ 6 months,
• Aged 18 years or older,
• Patients with chronic kidney disease,
• Can speak and understand Turkish and,
• Have a mobile phone and can use it will be included in the study.

You may not qualify if:

• Patients using psychotropic medication will not be included in the study.
• Patients who are unable to attend regular sessions will be excluded from the study.

Sponsors & Collaborators

• Bozok University: lead

Study Sites (1)

Gökmedrese Dialasis Center

Yozgat, Yozgat, 66100, Turkey (Türkiye)

Location

Related Publications (1)

• Akpinar, N. B., Unal, N., Alıncak, G., Pörücü, C., Yurtsever, S., & Karadurmus, N. (2025). The Power of Reiki: Its Effects on Pain and Biochemical Parameters in Patients Undergoing Bone Marrow Transplantation: A Randomized Prospective Controlled Study. Pain Management Nursing, 26(1), e24-e30.

  BACKGROUND

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant professor

Model Details: This study is planned to be conducted as a randomized controlled trial with two groups.

Study Record Dates

• First Submitted: December 4, 2025
• First Posted: February 6, 2026
• Study Start: July 10, 2025
• Primary Completion: August 10, 2025
• Study Completion: November 10, 2025
• Last Updated: February 6, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will share
• Shared Documents: SAP, CSR
• Time Frame: Beginning 6 months after publication of the primary study results and up to 5 years following publication of the primary study results
• Access Criteria: Researchers who provide a methodologically sound proposal and a reasonable scientific justification will be eligible to access the data. Requests should be submitted to the corresponding author via email. Data access may require approval by the principal investigator and the institutional ethics committee, where applicable. A data use agreement may be required prior to data sharing. Data will be available following publication of the primary study results and for a limited period thereafter.

Locations

TU (1)